Changmao Biochemical Engineering Company Limited (0954.HK)
HKD 0.31
(1.67%)
HKD 0.31
(1.67%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -8.25 Million CNY | -105.62% |
| 2022 | 122.51 Million CNY | 1346.15% |
| 2021 | 115.57 Million CNY | -120.52% |
| 2020 | 49.99 Million CNY | -50.12% |
| 2019 | 98.43 Million CNY | 11.46% |
| 2018 | 90.12 Million CNY | 113.55% |
| 2017 | 39.38 Million CNY | -39.09% |
| 2016 | 71.31 Million CNY | -19.99% |
| 2015 | 87.75 Million CNY | 6.21% |
| 2014 | 80.23 Million CNY | -32.19% |
| 2013 | 124.24 Million CNY | 28.35% |
| 2012 | 106.82 Million CNY | 7.11% |
| 2011 | 87.53 Million CNY | -22.43% |
| 2010 | 112.84 Million CNY | 41.0% |
| 2009 | 80.03 Million CNY | -2.75% |
| 2008 | 82.29 Million CNY | 21.27% |
| 2007 | 66.71 Million CNY | -25.92% |
| 2006 | 93.21 Million CNY | 99.23% |
| 2005 | 92.88 Million CNY | -21.37% |
| 2004 | 45.5 Million CNY | 42.63% |
| 2003 | 41 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 2.07 Million CNY | 0.0% |
| 2024 Q1 | 2.07 Million CNY | -87.87% |
| 2023 Q4 | 17.13 Million CNY | 0.0% |
| 2023 FY | - CNY | -105.62% |
| 2023 Q1 | 13.5 Million CNY | -57.84% |
| 2023 Q2 | 13.5 Million CNY | 0.0% |
| 2023 Q3 | 17.13 Million CNY | 26.86% |
| 2022 FY | - CNY | 1346.15% |
| 2022 Q3 | 32.04 Million CNY | 3.96% |
| 2022 Q4 | 32.04 Million CNY | 0.0% |
| 2022 Q1 | 30.82 Million CNY | 1249.74% |
| 2022 Q2 | 30.82 Million CNY | 0.0% |
| 2021 Q4 | -2.68 Million CNY | 0.0% |
| 2021 Q1 | 5.72 Million CNY | -26.12% |
| 2021 Q2 | 5.72 Million CNY | 0.0% |
| 2021 Q3 | -2.68 Million CNY | -146.85% |
| 2021 FY | - CNY | -120.52% |
| 2020 Q3 | 7.74 Million CNY | -57.89% |
| 2020 Q4 | 7.74 Million CNY | 0.0% |
| 2020 Q1 | 18.39 Million CNY | 12.2% |
| 2020 FY | - CNY | -50.12% |
| 2020 Q2 | 18.39 Million CNY | 0.0% |
| 2019 Q4 | 16.39 Million CNY | 0.0% |
| 2019 Q2 | 32.55 Million CNY | 0.0% |
| 2019 Q1 | 32.55 Million CNY | 18.38% |
| 2019 Q3 | 16.39 Million CNY | -49.63% |
| 2019 FY | - CNY | 11.46% |
| 2018 Q2 | 16.84 Million CNY | 0.0% |
| 2018 FY | - CNY | 113.55% |
| 2018 Q4 | 27.49 Million CNY | 0.0% |
| 2018 Q3 | 27.49 Million CNY | 63.2% |
| 2018 Q1 | 16.84 Million CNY | 129.26% |
| 2017 Q2 | 11.09 Million CNY | 0.0% |
| 2017 FY | - CNY | -39.09% |
| 2017 Q4 | 7.34 Million CNY | 0.0% |
| 2017 Q3 | 7.34 Million CNY | -33.74% |
| 2017 Q1 | 11.09 Million CNY | -3.54% |
| 2016 Q4 | 11.49 Million CNY | 0.0% |
| 2016 Q2 | 20.96 Million CNY | 0.0% |
| 2016 Q3 | 11.49 Million CNY | -45.14% |
| 2016 Q1 | 20.96 Million CNY | -9.28% |
| 2016 FY | - CNY | -19.99% |
| 2015 FY | - CNY | 6.21% |
| 2015 Q3 | 23.1 Million CNY | 40.76% |
| 2015 Q4 | 23.1 Million CNY | 0.0% |
| 2015 Q1 | 16.41 Million CNY | -17.4% |
| 2015 Q2 | 16.41 Million CNY | 0.0% |
| 2014 Q2 | 19.25 Million CNY | 0.0% |
| 2014 Q1 | 19.25 Million CNY | -39.63% |
| 2014 FY | - CNY | -32.19% |
| 2014 Q4 | 19.87 Million CNY | 0.0% |
| 2014 Q3 | 19.87 Million CNY | 3.2% |
| 2013 Q2 | 21.9 Million CNY | 31.67% |
| 2013 FY | - CNY | 28.35% |
| 2013 Q4 | 31.89 Million CNY | 0.0% |
| 2013 Q3 | 31.89 Million CNY | 45.66% |
| 2013 Q1 | 16.63 Million CNY | 3.88% |
| 2012 Q3 | 19.74 Million CNY | -23.74% |
| 2012 FY | - CNY | 7.11% |
| 2012 Q4 | 16.01 Million CNY | -18.91% |
| 2012 Q2 | 25.89 Million CNY | 188.67% |
| 2012 Q1 | 8.97 Million CNY | -14.03% |
| 2011 FY | - CNY | -22.43% |
| 2011 Q3 | 15.13 Million CNY | -16.14% |
| 2011 Q1 | 12.11 Million CNY | -62.73% |
| 2011 Q2 | 18.04 Million CNY | 48.94% |
| 2011 Q4 | 10.43 Million CNY | -31.04% |
| 2010 Q3 | 20.36 Million CNY | -2.38% |
| 2010 Q4 | 32.49 Million CNY | 59.6% |
| 2010 FY | - CNY | 41.0% |
| 2010 Q2 | 20.86 Million CNY | 0.0% |
| 2009 FY | - CNY | -2.75% |
| 2009 Q2 | 15.9 Million CNY | 0.0% |
| 2008 FY | - CNY | 21.27% |
| 2007 FY | - CNY | -25.92% |
| 2006 FY | - CNY | 99.23% |
| 2005 FY | - CNY | -21.37% |
| 2004 FY | - CNY | 42.63% |
| 2003 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 14.89 Million HKD | 155.409% |
| Lee & Man Chemical Company Limited | 597.01 Million HKD | 101.382% |